Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A strategy to use soft data effectively in randomized controlled clinical trials.

H C Kraemer, S Thiemann

    Journal of Consulting and Clinical Psychology
    |February 1, 1989
    PubMed
    Summary

    This study defines soft data and demonstrates how an intensive design using the slope of response over time enhances randomized clinical trials. This method boosts statistical power and sample retention without needing larger participant groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2015
    Same author

    Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.

    Diabetes, obesity & metabolism·2014
    Same author

    Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.

    Diabetes, obesity & metabolism·2012
    Same author

    Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.

    Diabetes, obesity & metabolism·2012
    Same author

    Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder.

    Molecular psychiatry·2012
    Same author

    Simultaneous evaluation of the harms and benefits of treatments in randomized clinical trials: demonstration of a new approach.

    Psychological medicine·2011

    Area of Science:

    • Biostatistics
    • Clinical Trial Design
    • Measurement Error

    Background:

    • Soft data, characterized by significant intrasubject variability, are crucial in clinical research.
    • Intrasubject variability arises from measurement errors and inconsistent participant responses.
    • Optimizing the analysis of soft data is essential for robust clinical trial outcomes.

    Purpose of the Study:

    • To define soft data and its implications in randomized clinical trials.
    • To propose an intensive design and specific outcome measure for analyzing soft data.
    • To evaluate the impact of this approach on statistical power and sample retention.

    Main Methods:

    • Defined soft data, emphasizing intrasubject variability from measurement error and response inconsistency.

    Related Experiment Videos

  • Employed an intensive study design.
  • Utilized the slope of response on time as the primary outcome measure.
  • Main Results:

    • The intensive design maximized sample retention.
    • The slope of response on time decreased within-group variability.
    • Statistical test power was maximized without increasing sample size.

    Conclusions:

    • An intensive design with the slope of response on time is an effective strategy for analyzing soft data in clinical trials.
    • This approach enhances statistical efficiency by reducing variability and improving sample retention.
    • The methodology offers a powerful tool for randomized clinical trials involving measures with high intrasubject variability.